Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Home Depot $2 billion notes offering
The investment-grade notes are due 2028, 2030 and 2035
Oesterreichische Kontrollbank $1.5 billion notes offering
The 3.75% notes are due 2030
Planet Labs PBC $460 million convertible senior notes offering
The 0.50% convertible senior notes are due 2030
Gemini Space Station $450 million IPO
The shares are listed on the Nasdaq Global Select Market
Alnylam Pharmaceuticals $661.25 million convertible senior notes offering
The 0% convertible notes are due 2028
Maze Therapeutics $150 million private placement
The PIPE included common stock and pre-funded warrants
Cinda HK $7.4 billion guaranteed note program update and offering
The issuer sold RMB8.1 billion aggregate of guaranteed notes due 2028, 2029 and 2030
DICK’S Sporting Goods exchange offer
The exchange offer included the issuance of new senior notes due 2029
Crane NXT €445 million acquisition of Antares Vision
We are advising Crane NXT on the transaction
Great Elm Capital $50 million notes offering
We advised Great Elm Capital on the offering